Published on
06:11 GMT
Liver-Targeting Nanoparticles GA-MSe@AR Treat NAFLD Through Dual Lipid-Lowering and Antioxidant Efficacy
Introduction Non-alcoholic fatty liver disease (NAFLD) has become increasingly prevalent due to modern lifestyle changes, affecting approximately 25% of the global adult population and representing the most common chronic liver disease-a major public …
Source:
Dove Medical Press
-
Neutral
